Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study

Recruiting N/A Interventional Study
Cognitive Impairment Alzheimer Blood Biomarkers Alzheimer Disease (AD) Mild Cognitive Impairment (MCI)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 – 75
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
200 (estimated)
Sponsor
HudsonAlpha Institute for Biotechnology · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Many individuals develop dementia, and dementia has multiple causes, yet we currently have limited treatment options. A critical observation of the effectiveness of the available dementia treatments is that they tend to be more effective when started early. Previous studies have shown that multimodal lifestyle interventions can significantly delay the onset of Alzheimer's dementia in individuals w…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults 65-75 years of age at enrollment with at least one self-reported 1st-degree relative who had or has any kind of dementia * Montreal Cognitive Assessment (MoCA) score \> 24 at initial enrollment * Able and willing to comprehend and sign the informed consent document * Ab…
Contacts

Jesse N Cochran, PhD

256-327-5262

ncochran@hudsonalpha.org

CONTACT